If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 176.20
Bid: 175.80
Ask: 176.60
Change: 4.00 (2.32%)
Spread: 0.80 (0.455%)
Open: 170.00
High: 178.20
Low: 170.00
Prev. Close: 172.20
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

20 May 2019 07:00

RNS Number : 4685Z
Forterra plc
20 May 2019
 

20 May 2019

Forterra plc

AGM Trading Update

 

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update for the four months ended 30 April 2019, ahead of its Annual General Meeting to be held later today.

 

Trading update

Trading during the period has been in line with management's expectations, underpinned by continuing positive levels of activity in the new build housing market, with brick sales volumes modestly ahead of last year. Precast concrete floor beam volumes in the period have been good, providing an encouraging forward indicator for housebuilding activity. As reported previously, price increases for the year have been agreed with most major customers to offset the increase in the cost base. Group revenue for the four months was 7.8% ahead of the same period in 2018, reflecting the positive start to 2019 and also the weather-affected weaker comparative. The Group continues to generate good levels of operating cashflow, despite an expected increase in working capital due to the spring selling season.

 

The productivity improvements seen in Bison Precast in the last quarter of 2018 have been sustained during the year to date, and the business has achieved contract wins supporting future sales volumes in hollowcore, beam and bespoke precast products.

 

Whilst we remain watchful of the impact of the current uncertainty on our end markets, based on the good start to the year as well as indications of demand from major customers, the Board's expectations for the full year remain unchanged.

 

Brick capacity expansion

The Group has now received planning consent (subject to legal agreement) for the £95m project to build a new brick facility at our existing site at Desford, Leicestershire, which we view as a significant positive development.

 

This major investment will lead to the construction of the largest and most efficient brick factory in Europe capable of producing up to 180 million bricks per annum. The existing plant, which has a capacity of 85 million bricks pa, will remain operational until the new facility constructed alongside is completed. It is anticipated that the new plant will commence full production during 2022 after a period of commissioning.

 

Contracts for the building work and equipment supply and installation are being finalised, and the project team mobilised in order to drive delivery of the project under the direction of the Group Executive and Board.

 

Dividend payout

In the Group's full year 2018 results statement, the Board confirmed its priorities for allocating capital as organic investment, dividends and appropriate acquisitions. It stated that it would continue following a progressive dividend policy reflecting the long-term earnings and cash flow potential of the Group whilst recognising that the business operates in cyclical markets.

 

As detailed above, once the major investment at Desford is completed, this will lead to a significant increase in earnings over the cycle based on the additional volume and the reduced cash cost of production for the plant compared with the existing facility. In view of this, the Board has decided to increase the dividend payout to 45% of earnings for 2019 and to maintain the progressive policy thereafter. This increase reflects the Board's confidence in the position of the Group and its future potential.

 

Board changes

As announced in September 2018, Paul Lester steps down as Chairman and Director of the Company with effect from the conclusion of the AGM today and will be succeeded by Justin Atkinson. The Board is also pleased to confirm that Katherine Innes Ker will become Senior Independent Non-Executive Director and Vince Niblett will take on the role of Chairman of the Audit Committee.

 

The Board would like to thank Paul for his immense contribution to Forterra and pay tribute to his leadership of the Group through the listing on the London Stock Exchange in April 2016 and its subsequent period of strong performance as a public company.

 

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

 

This announcement contains inside information and is disclosed in accordance with the Company's obligations under the Market Abuse Regulation (EU) No 596/2014

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTARMATMBABBTL
Date   Source Headline
2nd May 202410:46 amRNSGrant under Performance Share Plan
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.